Literature DB >> 28150372

Coexistent malignant conditions in rheumatoid arthritis - A population-based cross-sectional study.

Amir Dagan1,2, Gad Segal1,2, Shmuel Tiosano2,3, Abdulla Watad2,3, Shana G Neumann2,3, Doron Comaneshter4, Arnon D Cohen4,5, Howard Amital2,3.   

Abstract

OBJECTIVES: The aim of this study was to evaluate if association exist between rheumatoid arthritis and malignant diseases.
METHODS: A cross-sectional study was conducted comparing rheumatoid arthritis patients with age and gender matched controls regarding the proportion of patients with comorbid malignant conditions. Chi-square tests and t-tests were used for univariate analysis. A logistic regression model was used for multivariate analysis. The study was performed utilising the medical database of Clalit Health Services.
RESULTS: The study group included 11 782 rheumatoid arthritis patients and 57 973 controls. The total proportion of malignancies was significantly higher in the study group than in the control group (21.4% vs 11.2%; P<.001). The disease for which there was the strongest association among patients with rheumatoid arthritis was non-Hodgkin's lymphoma (1.1% vs 0.6%; P<.01). After multivariate analysis, lung cancer was not found to be significantly associated with rheumatoid arthritis.
CONCLUSION: Rheumatoid arthritis is associated with several malignant disorders, in particular non-Hodgkin's lymphoma. Appropriate measures for non-Hodgkin's lymphoma screening in this patient population should be considered.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28150372     DOI: 10.1111/ijcp.12929

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  4 in total

1.  Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis.

Authors:  JaeJin An; Eric Nyarko; Mohammad Adam Hamad
Journal:  Clin Rheumatol       Date:  2019-05-27       Impact factor: 2.980

2.  Calcium Channel Blocker Use and the Risk for Breast Cancer: A Population-Based Nested Case-Control Study.

Authors:  Victoria Rotshild; Bruria Hirsh Raccah; Muna Gazawe; Ilan Matok
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

3.  Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease.

Authors:  Chase S Correia; Melissa R Briones; Rong Guo; Rochella A Ostrowski
Journal:  Clin Rheumatol       Date:  2019-01-15       Impact factor: 2.980

4.  Cross-sectional analysis of the associations between fibromyalgia and diabetes mellitus.

Authors:  Adi Lichtenstein; Shmuel Tiosano; Doron Comaneshter; Howard Amital; Arnon D Cohen; Daniela Amital
Journal:  Reumatologia       Date:  2018-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.